TaiGen Biotechnology Co., Ltd.

Quick facts

Phase 2 pipeline

• Nemonoxacin 3 tablets
• TG-1000

Phase 1 pipeline

• ISM4808
• Nemonoxacin Malate Sodium Chloride
• TG-2349 as a new capsule formulation
• TG-2349 as the original formulation

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• TaiGen Biotechnology Co., Ltd. portfolio CI brief
• TaiGen Biotechnology Co., Ltd. pipeline updates RSS